About Us
Why exosomes
Services
Facility
|
News
Careers
Contact

Press

Corporate news Press
ExoXpert achieves two critical industry-first milestones for the exosome field
Liège, Belgium, December 2, 2024 – EXO Biologics and its CDMO subsidiary, ExoXpert, leading innovators in exosome-based therapeutics and…
December 2, 2024
•
Romain de Rauville

Want to be part of our team?

Applying for a job at ExoXpert and become a shaper of the exosome expansion

Apply now

Boulevard de Patience et Beaujonc
3/2 4000 Liège – Belgium

Created by

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options Manage services Manage {vendor_count} vendors Read more about these purposes

View preferences

{title} {title} {title}

Press

ExoXpert achieves two critical industry-first milestones for the exosome field